Aldosterone Excess Impairs First Phase Insulin Secretion in Primary Aldosteronism
The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
CONTEXT: Primary aldosteronism (PA) represents the most frequent cause of secondary arterial hypertension. Conflicting data have been published regarding the effect of aldosterone excess on glucose metabolism. OBJECTIVE: Our aim was to analyze insulin sensitivity and β-cell function in a cohort of PA patients. Prospective follow-up investigations were performed in a subgroup of patients before and after adrenalectomy to assess the metabolic outcome. DESIGN: Oral glucose tolerance test, combined intravenous glucose tolerance test, hyperinsulinemic-euglycemic glucose clamp test, and arginine test were carried out after a 12-hour fasting period. PATIENTS: Twenty-two consecutive patients with both unilateral aldosterone-producing adenoma and bilateral idiopathic adrenal hyperplasia were recruited through the Munich center of the German Conn's Registry. The control group of patients with essential hypertension (n = 11) of corresponding age and body mass index was recruited from our hypertension unit. A normotensive cohort (n = 11) served as a further control group. RESULTS: At baseline, first-phase insulin reaction in intravenous glucose tolerance test was significantly reduced in patients with PA as compared to normal controls (36.0 [24.0; 58.7] vs 90.1 [52.6; 143.8] μU/mL, P = .031) and lower in comparison to essential hypertension without reaching statistical significance (53.2 [30.8; 73.3] μU/mL, P = .123). The study was repeated 6 months after unilateral adrenalectomy in 9 consecutive patients with aldosterone-producing adenoma. At this time point, blood pressure had been normalized in most of the patients while body mass index remained unchanged (26.9 [25.5; 37.6] vs 27.5 [25.1; 35.6] kg/m(2), P = .401). First-phase insulin reaction in response to glucose significantly increased at follow-up (from 36.0 [25.5; 58.7] to 48.5 [40.4; 95.2] μU/mL, P = .038, n = 9). In contrast, insulin sensitivity and response to iv arginine did not differ before and after adrenalectomy. CONCLUSION: Aldosterone excess has a direct negative effect on β-cell function in patients with PA. After adrenalectomy, glucose-induced first-phase insulin secretion improves significantly in the patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with aldosterone-producing adenomas, insulin secretion and disposition index assessed with intravenous glucose tolerance tests increase after adrenalectomy”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [9]
In the citing paper
“Our finding of decreased insulin secretion in primary aldosteronism is consistent with a prior study which used a combined intravenous glucose tolerance test-hyperinsulinemic clamp to assess insulin secretion and insulin sensitivity in primary aldosteronism (9).”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [9]
In the citing paper
“However, the effects of hyperaldosteronism on insulin sensitivity and β-cell function are unclear.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [4]
In the citing paper
“Lastly, many of these studies were conducted in Europe or Japan [5,24,4,19,23] and thus not easily generalized to a more diverse and heterogenous US population.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [4]
In the citing paper
“Another study demonstrated an increased first-phase insulin response following unilateral adrenalectomy in nine PA patients, suggesting a direct negative effect of aldosterone on β-cell function [4].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [4]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Power and sample size calculations
Dupont, W. D., & Plummer, W. D. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90005-m · Cited by 2,092
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s055 · Cited by 1,062
The renin-angiotensin-aldosterone system: Past, present and future
Vecsei, P., Hackenthal, E., & Ganten, D. (1978) · Klinische Wochenschrift · doi:10.1007/bf01477448 · Cited by 604
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
Regulation of insulin secretion: a matter of phase control and amplitude modulation
Henquin, J. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1314-y · Cited by 496
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372
Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
Reaven, G. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030087 · Cited by 284
Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry
Reincke, M., Fischer, E., Gerum, S., Merkle, K., Schulz, S., Pallauf, A., Quinkler, M., Hanslik, G., Lang, K., Hahner, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197111 · Cited by 278
Self-citationInsulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
Born-Frontsberg, E., Reincke, M., Rump, L. C., Hahner, S., Diederich, S., Lorenz, R., Allolio, B., Seufert, J., Schirpenbach, C., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2116 · Cited by 261
Self-citationAhren, B., & Pacini, G. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500097 · Cited by 229
Plasma aldosterone is independently associated with the metabolic syndrome
Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231338.41548.fc · Cited by 226
Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
Kidambi, S., Kotchen, J. M., Grim, C. E., Raff, H., Mao, J., Singh, R. J., & Kotchen, T. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000253258.36141.c7 · Cited by 212
Primary aldosteronism: cardiovascular, renal and metabolic implications
Rossi, G.-P., Sechi, L. A., Giacchetti, G., Ronconi, V., Strazzullo, P., & Funder, J. W. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.01.006 · Cited by 204
Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280108e6f · Cited by 196
Ingelsson, E., Pencina, M. J., Tofler, G. H., Benjamin, E. J., Lanier, K. J., Jacques, P. F., Fox, C. S., Meigs, J. B., Levy, D., Larson, M. G., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.708537 · Cited by 195
The renin–angiotensin–aldosterone system and glucose homeostasis
Luther, J. M., & Brown, N. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.07.006 · Cited by 185
Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
Reincke, M., Rump, L. C., Quinkler, M., Hahner, S., Diederich, S., Lorenz, R., Seufert, J., Schirpenbach, C., Beuschlein, F., Bidlingmaier, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1851 · Cited by 175
Self-citationColussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155
The metabolic syndrome in hypertension: European society of hypertension position statement
Redon, J., Cifkova, R., Laurent, S., Nilsson, P., Narkiewicz, K., Erdine, S., & Mancia, G. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328302ca38 · Cited by 143
Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension
Lansang, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01229-2 · Cited by 116
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2158-9 · Cited by 109
Škrha, J., Haas, T., Šindelka, G., Prázný, M., Widimský, J., Cibula, D., & Svačina, Š. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030024 · Cited by 108
Betz, M. J., Degenhart, C., Fischer, E., Pallauf, A., Brand, V., Linsenmaier, U., Beuschlein, F., Bidlingmaier, M., & Reincke, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0287 · Cited by 106
Self-citationAdiponectin and Insulin Sensitivity in Primary Aldosteronism
FALLO, F., DELLAMEA, P., SONINO, N., BERTELLO, C., ERMANI, M., VETTOR, R., VEGLIO, F., & MULATERO, P. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.03.012 · Cited by 101
Is Primary Aldosteronism Associated with Diabetes Mellitus? Results of the German Conn's Registry
Reincke, M., Meisinger, C., Holle, R., Quinkler, M., Hahner, S., Beuschlein, F., Bidlingmaier, M., Seissler, J., & Endres, S. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246189 · Cited by 98
Self-citationAldosterone Production and Insulin Resistance in Healthy Adults
Garg, R., Hurwitz, S., Williams, G. H., Hopkins, P. N., & Adler, G. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2521 · Cited by 96
A possible association between primary aldosteronism and a lower β-cell function
Mosso, L. M., Carvajal, C. A., Maiz, A., Ortiz, E. H., Castillo, C. R., Artigas, R. A., & Fardella, C. E. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fa4 · Cited by 94
Characterization of insulin secretion and resistance in type 2 diabetes of adolescents
Druet, C., Tubiana-Rufi, N., Chevenne, D., Rigal, O., Polak, M., & Levy-Marchal, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1672 · Cited by 93
The effect of aldosterone on glucose metabolism
Corry, D. B., & Tuck, M. L. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0065-2 · Cited by 90
Fischer, E., Beuschlein, F., Bidlingmaier, M., & Reincke, M. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9163-7 · Cited by 88
Self-citationInsulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment
Šindelka, G., Widimský, J., Haas, T., Prázný, M., Hilgertová, J., & Škrha, J. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1329211 · Cited by 75
Primary Aldosteronism and Metabolic Syndrome
Fallo, F., Pilon, C., & Urbanet, R. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1295412 · Cited by 74
Apostolopoulou, K., Künzel, H. E., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Pallauf, A., Brand, V., Bidlingmaier, M., Endres, S., et al. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665480 · Cited by 73
Self-citationInsulin Resistance in Secondary Hypertension
Shamiss, A., Carroll, J., & Rosenthal, T. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.1.26 · Cited by 72
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.65 · Cited by 68
Effect of adrenal steroids on insulin release from cultured rat islets of Langerhans
Pierluissi, J., Navas, F. O., & Ashcroft, S. J. H. (1986) · Diabetologia · doi:10.1007/bf00456122 · Cited by 66
Genetic variation in aldosterone synthase predicts plasma glucose levels
Ranade, K., Wu, K. D., Risch, N., Olivier, M., Pei, D., Hsiao, C.-F., Chuang, L.-M., Ho, L.-T., Jorgenson, E., Pesich, R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221467098 · Cited by 60
Association of plasma aldosterone with the metabolic syndrome in two German populations
Hannemann, A., Meisinger, C., Bidlingmaier, M., Döring, A., Thorand, B., Heier, M., Belcredi, P., Ladwig, K.-H., Wallaschofski, H., Friedrich, N., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1074 · Cited by 57
Self-citationDoes insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?
Shimamoto, K., Shiiki, M., Ise, T., Miyazaki, Y., Higashiura, K., Fukuoka, M., Hirata, A., Masuda, A., Nakagawa, M., & Iimura, O. (1994) · PubMed · Cited by 50
Does the treatment of primary hyperaldosteronism influence glucose tolerance?
Štrauch, B., Widimsky, J., Šindelka, G., & Škrha, J. (2003) · Physiological Research · doi:10.33549/physiolres.930298 · Cited by 44
Pallauf, A., Schirpenbach, C., Zwermann, O., et al. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1299730 · Cited by 40
Self-citationHaluzík, M., Šindelka, G., Widimsky, J., Jr., Prázný, M., Zelinka, T., & Škrha, J. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001292 · Cited by 37
Impaired Insulin Action in Primary Hyperaldosteronism
Widimský, J., Šindelka, G., Haas, T., Prázný, M., Hilgertová, J., & Škrha, J. (2000) · Physiological Research · doi:10.33549/physiolres.930000.49.241 · Cited by 29
Kinetics of Insulin Secretion and Glucose Intolerance in Adult Patients with Cystic Fibrosis
Anzeneder, L., Kircher, F., Feghelm, N., Fischer, R., & Seißler, J. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0031-1275270 · Cited by 28
Self-citation
Cited by
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Targeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 325
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
“3) (n = 155) 134 (19) (n = 126) 78 (12) (n = 126) 32/162 20% 13/162 8%”
Self-citationHanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Self-citation
Metadata
- Authors
- Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M.
- Affiliations
- LMU Klinikum (DE)
- Helmholtz Munich (DE)
- Medizinische Klinik and Poliklinik IV, Campus Innenstadt (E.F., C.A., A.P., C.T., M.B., F.B., J.S., M.R.), Klinikum der Universität München, 80336 München, Germany
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-06-01
- Volume
- 98
- Issue
- 6
- Pages
- 2513-2520
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1987584539
- Cited by
- 88
- References
- 57
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 9 · 2021: 6 · 2020: 10 · 2019: 13 · 2018: 7 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 8 · 2013: 5
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, aldosterone excess, beta-cell function, insulin sensitivity, adrenalectomy, aldosterone-producing adenoma, secondary hypertension, glucose metabolism
- MeSH terms
- Insulin Secretion, Adult, Aldosterone, Blood Glucose, Female, Humans, Hyperaldosteronism, Hypertension, Insulin, Male, Middle Aged, Prospective Studies, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.